Jushi Holdings Reports FY2020 Revenues Of US$80.8 Million, US$211.9 Million Net Loss

Jushi Holdings Inc. (CSE: JUSH) released this morning its full-year financial results for 2020, highlighting an annual revenue of US$80.8 million in revenue. The results were notably delayed as a result of its auditing partner failing to get the necessary reports completed in time.

The company’s 2020 annual revenue is a notable increase from 2019’s revenue of US$10.2 million. Jushi has already previously announced unaudited financial results that showed Q4 2020’s revenue at US$32.3 million and Q1 2021’s revenue at US$41.7 million. The firm also reiterated that the increase in revenue is due to growth at its BEYOND/HELLO stores in Pennsylvania and Illinois, early revenue contributions from its Virginia retail operations, and increased operating activity at its PAMS and Nevada facilities.

Jushi’s gross margin for 2020 came in at 53.3%, a climb from last year’s gross margin of 47.2%. The company attributes the increase to improvement in revenue and an increase in unrealized gains on biological assets. Jushi previously stated that Q1 2021’s gross margin is at 48.2%, a decline from Q4 2020’s gross margin of 54.5%

The cannabis company recorded a US$211.9 million net loss for 2020, US$152.1 million of which was recorded in Q4 2020.  In comparison, the company saw a net loss of US$26.8 million in Q1 2021.

The annual net loss is a decline from 2019’s US$30.8 million net loss. Looking at the financials, a major contributor to 2020’s net loss is the cost of fair value changes in derivatives amounting to US$173.7 million. The 2020 net loss translates to US$2.11 loss per share.

However, the company’s adjusted EBITDA for 2020 is at negative US$2.6 million, compared to 2019’s adjusted EBITDA of negative US$27.5 million. On a quarterly basis, adjusted EBITDA for Q4 2020 is at US$2.6 million while Q1 2021 saw it increase to US$3.0 million.

Jushi ended 2020 with US$85.9 million in cash and cash equivalents, an increase from US$38.9 million in 2019. Jushi’s previously announced unaudited financials for Q1 2021 already saw cash and cash equivalents amounting to US$162.1 million for the quarter.

The company expects Q2 2021 to record a quarterly revenue between US$45 million to US$48 million and adjusted EBITDA between US$4 million to US$6 million.

You may view Jushi’s full financial results for 2020 here.

Jushi Holdings Inc. last traded at $7.38 on the CSE.


Information for this briefing was found via Sedar and the companies mentioned. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

New Found Gold: The Strategic Maritime Resources Purchase

Amex Exploration: Revised Perron PEA Has INSANE Economics

Aris Mining: The Multi Billion Dollar Soto Norte PFS

Recommended

Canadian Copper Secures $8 Million Lead Order From Ocean Partners As Part Of Larger Funding Round

Northern Superior Expands Philibert With 350 Metre Step Out Testing 1.10 g/t Gold Over 25.5 Metres

Related News

Jushi Acquires Vireo’s Pennsylvania Cultivation Assets, Announces Secured Financing

It appears that Vireo Health (CSE: VREO) is in the process of selling off assets....

Monday, June 22, 2020, 09:12:04 AM

Jushi Holdings To Raise $65.0 Million In Overnight Offering

Jushi Holdings (CSE: JUSH) has priced its overnight marketed offering this morning. The company will...

Wednesday, February 10, 2021, 09:23:34 AM

Jushi Reports Q1 2021 Revenue Of US$41.7 Million, $26.1 Million Net Loss

Jushi Holdings Inc. (CSE: JUSH) released its Q1 2021 financial results this morning, highlighting quarterly...

Friday, May 28, 2021, 09:12:46 AM

Jushi Enters State Of Massachusetts Following Closing Of Acquisition

Jushi Holdings (CSE: JUSH) has officially entered the State of Massachusetts. The company has entered...

Monday, September 13, 2021, 09:10:04 AM

Jushi Sees Franklin Bioscience Start Operations At New Ohio Facility

Jushi Holdings Inc. (CSE: JUSH) announced this morning that licensed medical marijuana processor Franklin Bioscience...

Wednesday, July 7, 2021, 10:49:00 AM